Scientists synthesize anti-inflammatory tick spit protein for first time

May 26, 2020



Anti-inflammatory proteins in tick saliva have been synthetically produced for the first time, a promising step towards new therapeutic treatments.

Evasins, as the proteins are known, act in human blood to suppress a class of transmitter proteins, which is why when bitten, we often don't notice a tick has burrowed into our skin. Scientists now want to see how these proteins can be used for treating human diseases, including potential application for lung inflammation in respiratory illness, such as COVID-19.

Their research is published today in , the Proceedings of the National Academy of Sciences of the United States of America.

"Ticks have a terrible reputation - they are not very nice to look at, need to suck blood to survive and are responsible for transmitting bacteria that cause severe diseases, such as Lyme disease in humans," said

"However, to a medicinal chemist, ticks are amazing creatures."

Ticks have evolved an impressive arsenal of biologically active salivary proteins they pump into the bite sites on their hosts. Among these are various pain-killing agents and some of the best blood-thinning molecules known.

"In order to avoid detection, ticks also produce small protein molecules that suppress the inflammatory response. These proteins are called the evasins because they help the tick evade immune detection. This means they can feed for days without the host knowing they are attached," Professor Payne said.

The proteins do this by binding to inflammatory molecules found within the blood called chemokines. In a normal infection or bite, the chemokines act as transmitters, letting the body know that white blood cells are needed to fight potential disease. The evasins therefore prevent the chemokines from causing inflammation at the bite site.

POWERFUL BIOLOGICAL KICK

In another first in her paper,

"Armed with this knowledge, evasins could potentially be repurposed to suppress chemokine-driven inflammation in human disease," she said.

PhD candidate Ms Franck said: "We've known about evasins in tick spit for more than a decade, but my discovery has shown that the proteins are modified with sulfate groups. It is these modified forms of the protein that provide a massive enhancement in biological activity."

When you try to isolate the evasins from the tick saliva, you end up with a big mixture of other molecules, making the evasins very difficult to test or reproduce.

"To overcome this, we built the proteins from scratch using synthetic chemistry," said Ms Franck, a student from Belgium. No one else has previously done this.

"We are now trying to engineer these sulfated evasin molecules to make them even more effective and more stable in blood," she said. "We can then start to explore how effective they could be for a range of inflammatory conditions in the clinic."

Evasin proteins without the sulfate modifications have been shown to have excellent anti-inflammatory properties in animal disease models of lung fibrosis and in colitis - a type of gut inflammation.

Chemokines have also been shown to be drivers of lung inflammation in COVID-19. The researchers say it will be worthwhile exploring how evasins might be used to treat these symptoms, but any practical application would be years in the future.

Professor Payne said: "It is entirely possible that our sulfated tick proteins, or modified variants of them, could find wide application for a number of inflammatory diseases in the future."

The work joins that of other research into naturally occurring proteins and their applications being undertaken by a new national centre funded by the Australian Research Council.

The ARC

Professor Payne is CIPPS Deputy Director. He said: "Life has had billions of years to exquisitely fine-tune proteins, such as evasins, for particular tasks. We have an amazing opportunity now to understand how they work and seek innovative ways to apply them to challenges in medicine and other areas to benefit humanity."

Professor Payne was awarded the Malcolm McIntosh Prize for

DOWNLOAD the research, photos of the researchers and an illustration

INTERVIEWS

Professor Richard Payne |
richard.payne@sydney.edu.au
School of Chemistry
Deputy Director ARC Centre for Innovations in Peptide and Protein Science
The University of Sydney

Charlotte Franck | charlotte.franck@sydney.edu.au
PhD candidate, School of Chemistry
The University of Sydney

MEDIA ENQUIRIES

Marcus Strom | marcus.strom@sydney.edu.au | +61 423 982 485

DECLARATION

This research was supported by an Australian Research Council Discovery Project (DP190101526) and a National Health and Medical Research Council Project Grant (APP1140867).

Charlotte Franck is generously supported a John A. Lamberton Research Scholarship.

University of Sydney

Related Proteins Articles from Brightsurf:

New understanding of how proteins operate
A ground-breaking discovery by Centenary Institute scientists has provided new understanding as to the nature of proteins and how they exist and operate in the human body.

Finding a handle to bag the right proteins
A method that lights up tags attached to selected proteins can help to purify the proteins from a mixed protein pool.

Designing vaccines from artificial proteins
EPFL scientists have developed a new computational approach to create artificial proteins, which showed promising results in vivo as functional vaccines.

New method to monitor Alzheimer's proteins
IBS-CINAP research team has reported a new method to identify the aggregation state of amyloid beta (Aβ) proteins in solution.

Composing new proteins with artificial intelligence
Scientists have long studied how to improve proteins or design new ones.

Hero proteins are here to save other proteins
Researchers at the University of Tokyo have discovered a new group of proteins, remarkable for their unusual shape and abilities to protect against protein clumps associated with neurodegenerative diseases in lab experiments.

Designer proteins
David Baker, Professor of Biochemistry at the University of Washington to speak at the AAAS 2020 session, 'Synthetic Biology: Digital Design of Living Systems.' Prof.

Gone fishin' -- for proteins
Casting lines into human cells to snag proteins, a team of Montreal researchers has solved a 20-year-old mystery of cell biology.

Coupled proteins
Researchers from Heidelberg University and Sendai University in Japan used new biotechnological methods to study how human cells react to and further process external signals.

Understanding the power of honey through its proteins
Honey is a culinary staple that can be found in kitchens around the world.

Read More: Proteins News and Proteins Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.